Replicel
Collapse
X
-
-
Re: cost, if Aderans, Replicel and Histogen all have marketable products, there will be a three-way battle for the chrome-dome dollar, and the price will be competitive.
Should be decently cheaper than a hair transplant because of the much lower labour costs involved. The only way it will cost $20,000 is if only one of them succeeds and the others fail, and they decide to monopolise it.Comment
-
Uninformed, they technically could, but I think that's less likely. I think about the participants in the study and the employees, they have families, friends, coworkers, etc. If the results were amazing, I'm not sure how at least one of those people couldn't help but let it leak unless there's some crazy incentive for them not to. That's just my opinion/logic of it, but I'll still hope for good results.Comment
-
Uninformed, they technically could, but I think that's less likely. I think about the participants in the study and the employees, they have families, friends, coworkers, etc. If the results were amazing, I'm not sure how at least one of those people couldn't help but let it leak unless there's some crazy incentive for them not to. That's just my opinion/logic of it, but I'll still hope for good results.Comment
-
Uninformed, they technically could, but I think that's less likely. I think about the participants in the study and the employees, they have families, friends, coworkers, etc. If the results were amazing, I'm not sure how at least one of those people couldn't help but let it leak unless there's some crazy incentive for them not to. That's just my opinion/logic of it, but I'll still hope for good results.
Second, they only had single injections. Any hair growth would only have been in a radius of a couple of millimetres. Unless they were injected on slick bald scalp these guys probably wouldn't even know themselves if they've grown any hair. It would take a microscope analysis.
Third, there's the fact they would have signed confidentiality agreements under threat of legal action. That's not just for results but everything about the procedure.
Fourth, there's the fact none of the other trial results have leaked. One guy turned up on another forum claiming to have been in an Aderans trial, and posted pics of hair growth, but there was no leak of results ("25% increase in hair count" or whatever). And that's it - from 300 trial participants! From Histogen participants we have heard absolutely squat.
Fifth, as uninformed said, there's just as much chance of a leak if it's bad news as if it's good.
So I don't really see that the fact there hasn't been a leak can be interpreted as good OR bad. We will see in a few days anyway.Comment
-
Well first up, the trial took place in Georgia, in the former USSR. Most of the participants probably don't even speak English. They certainly don't hang around hair loss forums. Or catch up with Tobin in a bar for a beer and a chat.
Second, they only had single injections. Any hair growth would only have been in a radius of a couple of millimetres. Unless they were injected on slick bald scalp these guys probably wouldn't even know themselves if they've grown any hair. It would take a microscope analysis.
Third, there's the fact they would have signed confidentiality agreements under threat of legal action. That's not just for results but everything about the procedure.
Fourth, there's the fact none of the other trial results have leaked. One guy turned up on another forum claiming to have been in an Aderans trial, and posted pics of hair growth, but there was no leak of results ("25% increase in hair count" or whatever). And that's it - from 300 trial participants! From Histogen participants we have heard absolutely squat.
Fifth, as uninformed said, there's just as much chance of a leak if it's bad news as if it's good.
So I don't really see that the fact there hasn't been a leak can be interpreted as good OR bad. We will see in a few days anyway.
People seem to think that a good result is a full head of hair and because there has been no leak (who would be able to hide a full head of hair and keep that a secret) then they must have failed. Come on guys, there is not a chance there will be anything like a full head of hair. But that doesn't mean they have failed. You are setting yourselves up for a major anti climax when you read the results in a few days.
Pate, do you have a link to the post from the Aderans trial patient? That sounds interesting, though there is no proof he was a patient I guess but I would like to read that.Comment
-
Well first up, the trial took place in Georgia, in the former USSR. Most of the participants probably don't even speak English. They certainly don't hang around hair loss forums. Or catch up with Tobin in a bar for a beer and a chat.
Second, they only had single injections. Any hair growth would only have been in a radius of a couple of millimetres. Unless they were injected on slick bald scalp these guys probably wouldn't even know themselves if they've grown any hair. It would take a microscope analysis.
Third, there's the fact they would have signed confidentiality agreements under threat of legal action. That's not just for results but everything about the procedure.
Fourth, there's the fact none of the other trial results have leaked. One guy turned up on another forum claiming to have been in an Aderans trial, and posted pics of hair growth, but there was no leak of results ("25% increase in hair count" or whatever). And that's it - from 300 trial participants! From Histogen participants we have heard absolutely squat.
Fifth, as uninformed said, there's just as much chance of a leak if it's bad news as if it's good.
So I don't really see that the fact there hasn't been a leak can be interpreted as good OR bad. We will see in a few days anyway.
Everyone needs to stop speculating... especially on the basis legal disclaimers, share prices or more strangely the lack of "leaks"....Comment
-
That's not saying subtle manipulations of dosage and/or repeated injections won't improve resultsComment
-
It worries me that 37% of the placebo group showed an increase in hair density. That shows me that those who were measuring the results wanted to see an increase. Even in a double blind situation they wanted positive results.
If someone understands this differently from me I'd be keen to hear your interpretation.Comment
-
The great news is that safety analysis is good. This and the fact that early efficacy analysis shows statistically significant hair growth means it will move forward and they will invest in the next clinical trial phase. Great news!
However, so far only 3.2% increase in terminal hair from baseline. So if I'm not mistaken their are no signs yet of this being an improved treatment compared to existing treatments available.
But this will hopefully be improved and Replicel are here to stay for the time being. Go Replicel!Comment
-
The great news is that safety analysis is good. This and the fact that early efficacy analysis shows statistically significant hair growth means it will move forward and they will invest in the next clinical trial phase. Great news!
However, so far only 3.2% increase in terminal hair from baseline. So if I'm not mistaken their are no signs yet of this being an improved treatment compared to existing treatments available.
But this will hopefully be improved and Replicel are here to stay for the time being. Go Replicel!
pessimistic guys.Comment
Comment